Tag Archives: acqusitions

September, 2016

21 September
Allergan Acquires Tobira Therapeutics for Up to $1.7 Billion

DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases, today announced that they have entered into a …
Share

13 January
Juno Therapeutics Acquires AbVitro, Adding Next-Generation Single Cell Sequencing Capabilities

SEATTLE–(BUSINESS WIRE)–Jan. 11, 2016– Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, announced today that it has acquired AbVitro, Inc., a privately held biotechnology company based in Boston, Massachusetts. The acquisition provides Juno with a leading next-generation …
Share